Literature DB >> 9565414

Health and developmental outcomes at 18 months in very preterm infants with bronchopulmonary dysplasia.

M C Grégoire1, F Lefebvre, J Glorieux.   

Abstract

OBJECTIVE: To determine whether very preterm infants who are oxygen-dependent at 28 days of life but not at 36 weeks' gestational age are at high risk of morbidities at 18 months. POPULATION: A total of 217 infants born in a tertiary care center at 24 to 28 weeks' gestation in 1987 to 1992, classified into three groups: neonatal comparison group, O2 <28 days of life (n = 76); bronchopulmonary dysplasia (BPD)-1, O2 >/=28 days but not at 36 weeks' gestational age (n = 48); and BPD-2, O2 >/=36 weeks (n = 93). OUTCOME MEASURES: Growth, persistent respiratory problems (asthma, tracheostomy, home oxygen therapy), surgery, hospitalizations, and neurodevelopmental impairments.
RESULTS: Among the three groups, no differences were found in weight, height, head circumference, or total number of days of rehospitalizations for any causes, or in rate of rehospitalizations to the intensive care unit, persistent respiratory problems, cerebral palsy, or sensory impairment. Children with BPD-2 needed more hernia repairs compared with the other two groups (comparison group: 12% vs BPD-1: 10% vs BPD-2: 30%), had more days of readmissions for respiratory problems (comparison group: 2.0 vs BPD-1: 2.0 vs BPD-2 6.3 [BPD-1 vs BPD-2]), had a lower mean developmental quotient (comparison group: 97.4 +/- 15.0 vs BPD-1: 97.9 +/- 11.6 vs BPD-2: 90.7 +/- 19.3). Intraparenchymal cerebral lesions, high family adversity, and prolonged ventilation were the most important factors influencing the developmental outcome.
CONCLUSION: Children with BPD-1 are similar in all respect at 18 months to children in the comparison group. Children with BPD-2 are similar to the other groups at 18 months in growth, general health, and neurologic outcome but differ in having a higher number of days of rehospitalizations for respiratory causes, more hernia repairs, and more developmental delays.

Entities:  

Mesh:

Year:  1998        PMID: 9565414     DOI: 10.1542/peds.101.5.856

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  17 in total

Review 1.  A risk-benefit assessment of drugs used for neonatal chronic lung disease.

Authors:  D G Sweet; H L Halliday
Journal:  Drug Saf       Date:  2000-05       Impact factor: 5.606

2.  Scope and impact of early and late preterm infants admitted to the PICU with respiratory illness.

Authors:  Cameron F Gunville; Marci K Sontag; Kristin A Stratton; Daksha J Ranade; Steven H Abman; Peter M Mourani
Journal:  J Pediatr       Date:  2010-03-24       Impact factor: 4.406

Review 3.  Prevention and treatment of bronchopulmonary dysplasia: contemporary status and future outlook.

Authors:  Laura Cerny; John S Torday; Virender K Rehan
Journal:  Lung       Date:  2008-01-30       Impact factor: 2.584

Review 4.  Understanding the Short- and Long-Term Respiratory Outcomes of Prematurity and Bronchopulmonary Dysplasia.

Authors:  Jessica Y Islam; Roberta L Keller; Judy L Aschner; Tina V Hartert; Paul E Moore
Journal:  Am J Respir Crit Care Med       Date:  2015-07-15       Impact factor: 21.405

Review 5.  Update on the diagnosis and management of bronchopulmonary dysplasia/chronic lung disease of infancy: what the radiologist should know.

Authors:  Richard B Parad
Journal:  Pediatr Radiol       Date:  2012-03-06

6.  Health Care and Societal Costs of Bronchopulmonary Dysplasia.

Authors:  Wannasiri Lapcharoensap; Henry C Lee; Amy Nyberg; Dmitry Dukhovny
Journal:  Neoreviews       Date:  2018-04

7.  Intensive care unit readmission during childhood after preterm birth with respiratory failure.

Authors:  Peter M Mourani; John P Kinsella; Gilles Clermont; Lan Kong; Amy M Perkins; Lisa Weissfeld; Gary Cutter; Walter T Linde-Zwirble; Steven H Abman; Derek C Angus; R Scott Watson
Journal:  J Pediatr       Date:  2013-12-31       Impact factor: 4.406

Review 8.  Emerging Clinical Benefits of New-Generation Fat Emulsions in Preterm Neonates.

Authors:  Gregory Guthrie; Muralidhar Premkumar; Douglas G Burrin
Journal:  Nutr Clin Pract       Date:  2017-01-27       Impact factor: 3.080

Review 9.  Prevention of bronchopulmonary dysplasia: finally, something that works.

Authors:  Virender K Rehan
Journal:  Indian J Pediatr       Date:  2006-11       Impact factor: 1.967

10.  Chronic lung disease and developmental delay at 2 years of age in children born before 28 weeks' gestation.

Authors:  Matthew Laughon; Michael T O'Shea; Elizabeth N Allred; Carl Bose; Karl Kuban; Linda J Van Marter; Richard A Ehrenkranz; Alan Leviton
Journal:  Pediatrics       Date:  2009-07-20       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.